Kaushik Ghoshal Resmed Inc (RSMDF) insider trading activity

Kaushik Ghoshal is Chief Commercial Officer, SaaS of RESMED INC. Currently has a direct ownership of 9,725 shares of RSMDF, which is worth approximately $0. The most recent transaction as insider was on Nov 11, 2024, when has been sold 2,465 shares (ResMed Common Stock) at a price of $252.38 per share, resulting in proceeds of $622,116. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.73K

55.37% 3M change

24.66% 12M change

Total Value Held $0

Kaushik Ghoshal Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 11 2024	SELL Payment of exercise price or tax liability	$622,116 $252.38 p/Share	2,465 Reduced 20.22%	9,725 ResMed Common Stock
Oct 30 2024	SELL Other acquisition or disposition	-	9,628 Reduced 44.19%	12,160 ResMed Common Stock
Oct 11 2024	SELL Open market or private sale	$1,015,924 $238.48 p/Share	4,260 Reduced 16.35%	21,788 ResMed Common Stock
Oct 11 2024	BUY Exercise of conversion of derivative security	$432,986 $101.64 p/Share	4,260 Added 14.06%	26,048 ResMed Common Stock
Sep 12 2024	SELL Open market or private sale	$1,262,800 $252.56 p/Share	5,000 Reduced 18.67%	21,788 ResMed Common Stock
Sep 12 2024	BUY Exercise of conversion of derivative security	$508,200 $101.64 p/Share	5,000 Added 15.73%	26,788 ResMed Common Stock
Aug 15 2024	BUY Grant, award, or other acquisition	-	8,756 Added 28.67%	21,788 ResMed Common Stock
Aug 12 2024	SELL Open market or private sale	$2,166,000 $216.6 p/Share	10,000 Reduced 43.42%	13,032 ResMed Common Stock
Aug 12 2024	BUY Exercise of conversion of derivative security	$977,500 $97.75 p/Share	10,000 Added 30.27%	23,032 ResMed Common Stock
Nov 20 2023	SELL Payment of exercise price or tax liability	$54,512 $148.94 p/Share	366 Reduced 2.76%	12,908 ResMed Common Stock
Nov 13 2023	SELL Payment of exercise price or tax liability	$147,190 $143.6 p/Share	1,025 Reduced 7.17%	13,275 ResMed Common Stock
Aug 17 2023	BUY Grant, award, or other acquisition	-	2,486 Added 14.83%	14,273 ResMed Common Stock
Jul 13 2023	SELL Open market or private sale	$110,000 $220.0 p/Share	500 Reduced 4.07%	11,787 ResMed Common Stock
Jun 02 2023	SELL Open market or private sale	$110,000 $220.0 p/Share	500 Reduced 3.91%	12,287 ResMed Common Stock
May 01 2023	SELL Open market or private sale	$119,650 $239.3 p/Share	500 Reduced 3.79%	12,704 ResMed Common Stock
Apr 24 2023	SELL Open market or private sale	$460,000 $230.0 p/Share	2,000 Reduced 13.15%	13,204 ResMed Common Stock
Apr 03 2023	SELL Open market or private sale	$110,000 $220.0 p/Share	500 Reduced 3.18%	15,204 ResMed Common Stock
Mar 03 2023	SELL Open market or private sale	$220,000 $220.0 p/Share	1,000 Reduced 5.99%	15,704 ResMed Common Stock
Nov 23 2022	SELL Payment of exercise price or tax liability	$968,959 $224.4 p/Share	4,318 Reduced 20.54%	16,704 ResMed Common Stock
Nov 23 2022	BUY Grant, award, or other acquisition	-	7,288 Added 25.74%	21,022 ResMed Common Stock
Nov 11 2022	SELL Payment of exercise price or tax liability	$202,211 $225.18 p/Share	898 Reduced 6.14%	13,734 ResMed Common Stock
Aug 18 2022	BUY Grant, award, or other acquisition	-	3,366 Added 18.71%	14,628 ResMed Common Stock
Nov 18 2021	BUY Grant, award, or other acquisition	-	697 Added 5.87%	11,171 ResMed Common Stock
Nov 17 2021	SELL Payment of exercise price or tax liability	$1,302,589 $254.81 p/Share	5,112 Reduced 32.8%	10,474 ResMed Common Stock
Nov 16 2021	BUY Grant, award, or other acquisition	$2,334,569 $254.81 p/Share	9,162 Added 37.02%	15,586 ResMed Common Stock

Also insider at

OMCL

OMNICELL, Inc Healthcare

Kaushik Ghoshal

Chief Commercial Officer, SaaS

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RSMDF shares.

Notify only if

Value

Insider Trading

Get notified when an Resmed Inc insider buys or sells RSMDF shares.

Notify only if

Operation

Value

Type

News

Receive news related to RESMED INC

Track Activities on RSMDF

Account